GANX icon

Gain Therapeutics
GANX

Overview Fund Activity

14 hedge funds and large institutions have $6.65M invested in Gain Therapeutics in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TI
1
Telemetry Investments
New York
$716K
2
CM
2
CM Management
Florida
$479K
3
IAP
3
Indie Asset Partners
Indiana
$221K
4
V
4
Veritable
Delaware
$187K
5
UBS Group
5
UBS Group
Switzerland
$51K

Top Sellers

1
GPCM
1
Granite Point Capital Management
Massachusetts
$0
2
Millennium Management
2
Millennium Management
New York
$0
3
BlackRock
3
BlackRock
New York
$85K
Name Market Value Shares Shares
Change 		Shares
Change %
GC
1
Greenlight Capital
New York
$4.07M 546,560 – –
TI
2
Telemetry Investments
New York
$716K 96,232 +65,939 +218%
CM
3
CM Management
Florida
$479K 64,327 +54,327 +543%
PCM
4
Prelude Capital Management
New York
$433K 58,100 – –
BCM
5
Bridgeway Capital Management
Texas
$372K 50,000 – –
IAP
6
Indie Asset Partners
Indiana
$221K 29,652 +29,652 New
V
7
Veritable
Delaware
$187K 25,064 +25,064 New
BlackRock
8
BlackRock
New York
$85K 11,476 -183 -2%
UBS Group
9
UBS Group
Switzerland
$51K 6,740 +2,640 +64%
BCV
10
Banque Cantonale Vaudoise
Switzerland
$22K 3,000 – –
Morgan Stanley
11
Morgan Stanley
New York
$6K 800 – –
TRCT
12
Tower Research Capital (TRC)
New York
$4K 555 +483 +671%
SPIA
13
Steward Partners Investment Advisory
New York
$1K 100 – –
GPCM
14
Granite Point Capital Management
Massachusetts
– – -155,709 Closed
Millennium Management
15
Millennium Management
New York
– – -23,878 Closed
Wells Fargo
16
Wells Fargo
California
$0 23 -1 -4%
CFGS
17
Concourse Financial Group Securities
Alabama
– – – –